Manuela Callari

Science and Medical Writer Sydney
Manuela Callari, PhD, is an award-winning freelance science and medical journalist. She has a PhD in medical science, a bachelor’s and a master’s degree in material science, and a post-graduate degree in science communication.

More from this expert

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Clinical Articles iconClinical Articles

Which factors predict better outcomes with GLP-1 RAs and their successors...

Clinical Articles iconClinical Articles